Skip to main content
. 2019 Apr 8;18:122. doi: 10.1186/s12936-019-2755-5

Fig. 2.

Fig. 2

The standardized marginal cost of increasing treatment coverage. Treatment coverage is increased from 0 to 50% (blue boxes) or 75% (orange boxes) with respect to LLIN access. Increasing LLIN coverage prevents cases and therefore reduces the cost of increasing treatment coverage. In a low (baseline PfPr2-10: 10%) and b medium (baseline PfPr2-10: 30%) transmission settings the marginal impact of scaling LLINs decreases and treatment becomes a relatively cost-effective choice before coverage of LLINs is maximized. In the c high (baseline PfPr2-10: 60%) transmission settings transmission continues to decrease even as LLINs reach very high levels of coverage